Don't miss this Noid Factoid from Nathan Johnson, PhD, the Co-Founder and CEO of VERNE Bioanalytics.
Listen as Nathan Johnson, PhD, Co-Founder and CEO of VERNE Bioanalytics., shares a quick Noid Factoid with us!
On this month’s episode, we are joined by Nathan Johnson, PhD, the Co-Founder and CEO of VERNE Bioanalytics. Join us as we discuss Nathan’s background, knowledge about cannabis genetics, some of the challenges related to hops latent viroid, and more.
Hear more of what Nathan has to say in the full Noid Knowledge podcast episode: https://www.cannabissciencetech.com/view/ep-15-hot-topics-in-cannabis-cultivation-hops-latent-viroid-genetics-and-more.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.